Family Promise: Get Tested for Hepatitis B
Video by CDC & Hep B United
Last Updated on July 24, 2023 by HepFree NYC
Related Articles
-
New Two-Dose Hep B Vaccine Recommended by the Advisory Committee on Immunization Practices
The Advisory Committee on Immunization Practices’ (ACIP) recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV).
-
NYS Medicaid Adds Epclusa and Viekira XR to Preferred Hep C Med List
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
-
Press Release | 2016 World Hepatitis Day (NYC Health Dept)
Study shows that two out of five Bronx residents who test positive for hepatitis C are undiagnosed. The Health Department’s Viral Hepatitis Program offers free resources to support health care providers in hepatitis B and C screening and care.
-
Paid Interview | Hep C Patients on/not on treatment
RRU Research (Formerly Recruiting Resources Unlimited) has been locating qualified research participants for over 35 years. Our focus groups and interviews are broad in scope, yet small and informal, making it easy for respondents to express ideas and opinions. Your participa...
-
Un réseau d’organisations pour l’augmentation de nos capacités de prévenir, gérer et traiter les hépatites B et C à New York City
To build community and provider partnerships for prevention, raise awareness, provide screening, immunization and referral services, and reduce cultural and language barriers for treatment for liver diseases for African immigrants and refugees.
-
NYS Attorney General to Investigate Insurers Over Hep C Drug Coverage
The NYS attorney general has asked 16 health insurance companies for information on their coverage of Hepatitis C treatments, amid concerns that some companies are restricting coverage of the medications.
-
Hep C Medication Prior Authorization Requirements Reduced in NYS Fee for Service Medicaid
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
-
CDC Viral Hepatitis Strategic Plan – 2020
This Plan updates the Center’s current strategic plan and serves as a blueprint for achieving our vision of a future free of HIV, viral hepatitis, STDs, and TB.
){kind=link}